MedTrace Logo

Pilot Study of Neurovision to Improve Vision and Slow Myopia Progression in Children With Myopia

NCT00348218 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2010-05-12

No results posted yet for this study

Summary

This is a pilot study to assess the effectiveness of Neurovision treatment in the improvement of vision in children being under-corrected and to assess the effectiveness of Neurovision treatment in slowing down myopia progression in children.

Conditions

  • Myopia

Interventions

DEVICE

NeuroVision

Sponsors & Collaborators

  • NeuroVision

    collaborator INDUSTRY

  • Health Promotion Board, Singapore

    collaborator OTHER_GOV

  • Singapore National Eye Centre

    lead OTHER_GOV

Principal Investigators

  • Donald Tan, FRCS · Singapore Eye Research Institute

  • Wei Han Chua, FRCS · Singapore National Eye Centre

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00348218 on ClinicalTrials.gov